Serious Situation: Surging Bankruptcies in Medical Institutions! Around 1,000 Businesses May “Disappear” This Year [Latest Teikoku Databank Survey] – Diamond Online

News Highlights

According to a survey by Teikoku Databank, medical institutions are expected to see a surge in bankruptcies in 2025, with approximately 1,000 businesses potentially disappearing. This is believed to be due to a combination of factors, including the end of COVID-19 support measures, rising prices, and increasing labor costs. Early consultation with experts is key to maximizing options when signs of management deterioration, such as a worsening current ratio or consecutive deficits, become apparent. M&A while still in a sound financial state can create room for negotiating the release of the clinic director’s personal guarantees and contribute to the maintenance of regional healthcare.

Perspective from M&A Medical Editorial Department

Teikoku Databank’s projection that “bankruptcies of medical institutions will reach the scale of 1,000 cases” signifies more than just numbers. It particularly highlights the current situation where the “temporary tailwinds” of revised medical fees and subsidies during the COVID-19 pandemic have ended, and structural headwinds like soaring prices and rising labor costs are intensifying. Declining operating profit margins and a worsening current ratio are not merely deteriorations in management indicators, but precursors to the crisis of healthcare providers in the region “disappearing.” In this context, M&A while the financial base is still maintained to some extent, referred to as “while still sound,” is the only opportunity for medical institutions facing challenges such as lack of successors or management difficulties to negotiate the release of the clinic director’s personal guarantees. To avoid the option of closure, early consultation on business succession and M&A is highly likely to be the only path forward to protect patients, staff, and regional healthcare.

Points Raised by This News

• The end of COVID-19 support and structural cost increases may lead to a rush of bankruptcies
• To avoid “disappearance,” M&A should be considered early upon signs of management deterioration
• The release of personal guarantees for clinic directors hinges on M&A conducted in a sound financial state
• Business succession, rather than closure, is essential for the continuation of regional healthcare

Practical Questions Arising from This News

• For how long, specifically, is a period of deficits considered “management deterioration”?
• Under what conditions can the release of personal guarantees be negotiated?
• If M&A is not successful, what is the specific process leading up to closure?

If You Feel “Should I Consult?”

If the figure of “1,000 cases this year” has shocked you, calmly analyze your own medical institution’s financial situation. If signs such as a worsening current ratio or consecutive deficits in operating profit margins are apparent, it may be a countdown to “disappearance.” If you are facing a lack of successors or management difficulties and are considering the release of personal guarantees, now is the best time to consult with experts. Early consultation will broaden your options and lead to the realization of a better succession scheme.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a completely success-fee-based system. Consultations are accepted with strict confidentiality. Free consultation here